Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Immunogen
Immunogen
This Just In: More Upgrades and Downgrades
Motley Fool
Sat, 08/25/12 - 11:38 am
Discovery Labs
Oncothyreon
Threshold Pharmaceuticals
Puma Biotechnology
Immunogen
Pharmacyclics
Infinity Pharmaceuticals
Six Disruptive Biotech Stocks
Motley Fool
Sat, 08/18/12 - 03:51 pm
Dendreon
Seattle Genetics
Immunogen
Roche
Vertex Pharmaceuticals
Aveo
Ariad Pharmaceuticals
Isis Pharmaceuticals
ImmunoGen slips after forecasting bigger loss
Yahoo/AP
Sat, 08/4/12 - 11:17 am
Immunogen
Why ImmunoGen Shares Plunged
Motley Fool
Thu, 07/12/12 - 07:32 pm
Immunogen
Roche
Protesters push FDA on breast cancer drug at BIO conference
Bizjournals.com
Wed, 06/20/12 - 12:33 pm
FDA
breast cancer
BIO Conference
T-DM1
Immunogen
Roche
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
ImmunoGen's Good News: No 'If's, 'And's, Or 'But's
Seeking Alpha
Tue, 06/5/12 - 12:21 pm
Immunogen
ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013
Yahoo/AP
Mon, 06/4/12 - 05:54 pm
Immunogen
Roche
breast cancer
T-DM1
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics
ImmunoGen fiscal 3Q loss widens as expenses rise
Yahoo/AP
Fri, 04/27/12 - 11:43 am
earnings
Immunogen
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Dendreon May See Massive Gains By 2013 On Provenge
Seeking Alpha
Fri, 04/13/12 - 08:29 am
Dendreon
Provenge
JNJ
Medivation
prostate cancer
Immunogen
Seattle Genetics
This Cancer Drug Works, but Indication Drama Remains
Motley Fool
Sat, 03/31/12 - 12:17 pm
Immunogen
Roche
trastuzumab
ImmunoGen Rises After Drug Delays Cancer Worsening in Study
Bloomberg
Fri, 03/30/12 - 12:01 pm
Immunogen
breast cancer
Roche
T-DM1
ImmunoGen fiscal 2Q loss shrinks on milestone pay
Yahoo/AP
Fri, 01/27/12 - 11:33 am
earnings
Immunogen
10 Biotech Stocks With Strong Corporate Governance
Seeking Alpha
Wed, 01/18/12 - 10:03 am
Amgen
Achillion
Chelsea Therapeutics
Charles River Laboratories
Indenix
Human Genome Sciences
Incyte
Immunogen
NPS Pharmaceuticals
PDL Biopharma
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
6 Biotech Stocks With Consistently Rising Liquidity
Seeking Alpha
Fri, 12/23/11 - 08:49 am
Enzon
Immunogen
Micromet
Oncothyreon
Vivus
QLT
Eli Lilly and Immunogen enter development deal for potential cancer treatments
Yahoo/AP
Tue, 12/20/11 - 11:05 am
Eli Lilly
Immunogen
Targeted Antibody Payload
cancer
Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment
Yahoo/AP
Thu, 10/20/11 - 12:45 pm
Immunogen
Sanofi
SAR3419
non-Hodgkin's lymphoma
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »